STERIS plc
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from STERIS plc's yearly results (2023–2026), compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
What stands out
- Steadiness Ratio: Sales and profit both grew in each of the last 3 years. Steadier than 96% of Healthcare companies in United States.
- Debt Due Cover Ratio: Debt due within a year is covered 11.3 times by its yearly operating cash. Higher than 86% of Healthcare companies in United States.
Where $100 of sales goes
Latest year (Mar 2026). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
$195Over the last 3 years, every $100 of reported profit came with $195 of operating cash.
Higher than 75% of Healthcare companies in United States.
Self-Funding Ratio
3.1×Over the last 3 years its own operating cash covered its investment spending (capex) 3.1 times.
Higher than 79% of Healthcare companies in United States.
Cash Locked Ratio
$23For every $100 of sales, $23 is tied up in day-to-day operations (money owed by customers + stock − money owed to suppliers), against $26 tied up three years earlier.
Less money tied up than 52% of Healthcare companies in United States.
Growth quality
Steadiness Ratio
3/3 · 3/3Sales and profit both grew in each of the last 3 years.
Steadier than 96% of Healthcare companies in United States.
Growth Efficiency Ratio
$48Sales grew 31% in 3 years; of every extra $100 of sales, $48 became extra profit.
Higher than 69% of Healthcare companies in United States.
Asset Productivity Ratio
+31% / -1%In 3 years sales changed by +31% while total assets changed by -1%. Sales grew faster than assets.
Balance-sheet strength
Debt Due Cover Ratio
11.3×Debt due within a year is covered 11.3 times by its yearly operating cash.
Higher than 86% of Healthcare companies in United States.
Cash Cushion Ratio
−7%Debt, after subtracting cash, equals 7% of its market value (net debt).
Lower than 76% of Healthcare companies in United States.
Tangible Assets Ratio
46%Of every $100 the company owns, $46 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
Less tangible than 84% of Healthcare companies in United States.
Tangible Net Worth Ratio
19%Of every $100 of net worth, $19 is tangible; the rest is goodwill and other intangibles, often from buying other companies.
Less tangible than 66% of Healthcare companies in United States.
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (14)
STERIS plc owes $0.33 for every $1 it owns. Net profit rose 27% in the year to Mar 2026, and grew 94% a year on average over 3 years.
Compared with Healthcare companies in United States · latest annual results Mar 2026.
P/E ratio
28.4Investors pay $28.4 for every $1 of STERIS plc's yearly profit, higher than 55% of Healthcare companies in United States.
P/B ratio
3.14The share price is 3.14 times STERIS plc's book value per share, higher than 57% of Healthcare companies in United States.
Market cap
$22.6 BThe total market value of all of STERIS plc's shares at today's price (share price × number of shares), larger than 94% of Healthcare companies in United States. PosiCap size class: Tito Cap.
Net worth (book value)
$7.2 BWhat STERIS plc would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Book value per share
$73.91Net worth divided by the number of shares. The share price of $232.22 is 3.1 times this, which is the P/B above.
Return on equity (ROE)
11.4%STERIS plc earned 11.4% on its shareholders' money over the last year, higher than 85% of Healthcare companies in United States.
Owes vs Owns
0.33×STERIS plc owes $0.33 for every $1 it owns (low), lower than 57% of Healthcare companies in United States.
Dividend yield
1.16%STERIS plc pays 1.16% of its share price as dividends a year, higher than 54% of dividend-paying Healthcare companies in United States.
Revenue growth
+9%Revenue rose 9% in the year to Mar 2026, and grew 9% a year on average over 3 years.
Profit growth
+27%Net profit rose 27% in the year to Mar 2026, and grew 94% a year on average over 3 years.
Profit margin
13.2%STERIS plc keeps $13 of every $100 of revenue as net profit.
Cash quality
1.7×Cash from STERIS plc's business was 1.7× its reported profit in the year to Mar 2026 — its profit turned into cash.
Interest cover
18.2×STERIS plc's operating profit covered its interest costs 18.2 times in the year to Mar 2026.
Cash vs debt
Net debtSTERIS plc had $1.6 B more debt than cash (net debt) at Mar 2026.
Questions
What is STERIS plc's P/E ratio?
Investors pay $28.4 for every $1 of STERIS plc's yearly profit, higher than 55% of Healthcare companies in United States.
How is P/B calculated on PositoAI?
P/B is market cap divided by net worth from the latest balance sheet. For STERIS plc: $22.6 B ÷ $7.2 B (30 Jun 2026) = 3.1.
What is STERIS plc's return on equity?
STERIS plc earned 11.4% on its shareholders' money over the last year, higher than 85% of Healthcare companies in United States.
How much does STERIS plc owe compared with what it owns?
STERIS plc owes $0.33 for every $1 it owns (low), lower than 57% of Healthcare companies in United States.
Does STERIS plc pay a dividend?
Yes. STERIS plc pays 1.16% of its share price as dividends a year, higher than 54% of dividend-paying Healthcare companies in United States.
Is STERIS plc's revenue growing?
Revenue rose 9% in the year to Mar 2026, and grew 9% a year on average over 3 years.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.